Comment on: Intravenous iron for critically ill children. Comparison of three dose regimens

Abstract

Butragüeño-Laiseca et al. 1 present a nonrandomized intervention study on 115 critically ill children treated with intravenous (IV) iron sucrose. They claim its safety and efficacy in treating anemia with iron deficiency (ID), but the study's limitations raise concerns about accepting this conclusion.

Reply to: Comment on: Intravenous iron for critically ill children. Comparison of three dose regimens

“…Laura Butragueño-Laiseca 1,2, 3,4 Sara de la Mata Navazo 1,2,3,4 Amelia Caridad Sánchez Galindo 1,2,3,4 María José Santiago Lozano…”